Answer
During asparaginase treatment, rare severe liver impairment can occur, including cholestasis, jaundice, hepatic necrosis and hepatic failure with a fatal outcome.
Sources for this answer
- Spectrila 10,000 U powder for concentrate for solution for infusionmedac Pharma LLP · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked